Latest news
September 28, 2018
The Japanese Cancer Association and Debiopharm Group Announce Winners of the 2018 JCA-Mauvernay Award
July 24, 2018
Debiopharm Investment, BNP Paribas Développement, Bpifrance et Tikehau Capital accompagnent la croissance du groupe Carbonex
May 8, 2018
FDA Grants Fast Track designation to Debiopharm International’s Debio 1347 for the treatment of patients with unresectable or metastatic tumors…
April 5, 2018
Kaiku Health raises €4.4 million series A financing to accelerate its digital therapeutics pipeline led by Debiopharm and Tesi
February 15, 2018
Debiopharm continues the fight against antibiotic resistance with investment in ABAC Therapeutics Inc.